个人简介

钟文昭教授，胸部肿瘤外科学博士。广东省肺癌研究所所长，广东省人民医院惠福分院（肿瘤医院）副院长，广东省肺癌转化医学重点实验室主任，二级教授，主任医师，南方医科大学博士生导师。全球前2%高被引学者，国家万人计划科技创新领军人才。华南理工大学医学院、广东医科大学博士生导师。中国临床肿瘤学理事，青委副主委，肺癌专业组长；中国医院协会健康医疗大数据专委会常委；中华医学会肿瘤早诊早诊学组副组长；国际肺癌联盟IASLC官方杂志(Journal of Thoracic Oncology，IF 15.6)副主编；广东省医学会肺部肿瘤学分会副主任委员。以第一完成人获2020年广东省科学技术进步奖一等奖，荣获第十六届广东省丁颖科技奖。主要方向以肺癌外科为主单病种多学科综合治疗，包括IIIA期N2肺癌、肺部孤立结节/肺腺癌/GGO分类诊断和处理、胸腔镜微创肺癌根治术、肺癌病理分类和临床实践、人工智能影像-液体活检肺癌早筛分诊系统等；主持四项国家自然科学基金，在肿瘤学高影响力杂志，包括Lancet Oncology，Journal Of Clinical Oncology*3，Journal of Thoracic Oncology*5，Journal of Extracellular Vesicles等，在国际胸心外科四大期刊：JTCVS、ATS、EJCTS、IVCTS发表原创性成果。参与制定《中国临床肿瘤学会原发性肺癌诊疗指南》，共同主编《肺腺癌病理新分类和临床实践》，参编《胸心外科学》研究生卫生部规划教材，受邀担任世界肺癌大会外科专场主席。

研究领域

主要方向以肺癌外科为主单病种多学科综合治疗，包括IIIA期N2肺癌、肺部孤立结节/肺腺癌/GGO分类诊断和处理、胸腔镜微创肺癌根治术、肺癌病理分类和临床实践、人工智能影像-液体活检肺癌早筛分诊系统等。

个人成果

(1) Wenzhao Zhong; Qun Wang; Weimin Mao; Songtao Xu; Lin Wu; Yucheng Wei; Yongyu Liu; Chun Chen; Ying Cheng; Rong Yin; Fan Yang; Shengxiang Ren; Xiaofei Li; Jian Li; Cheng Huang; Zhidong Liu; Shun Xu; Keneng Chen; Shidong Xu; Lunxu Liu; Ping Yu; Buhai Wang; Haitao Ma; Jinji Yang; Honghong Yan; Xuening Yang; Siyang Liu; Qing Zhou; Yilong Wu; Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial, Journal of Clinical Oncology, 2020, 39(7):713-722.

(2) Wenzhao Zhong; Keneng Chen; Chun Chen; Chundong Gu; Jun Wang; XueNing Yang; Weimin Mao; Qun Wang; Guibin Qiao; Ying Cheng; Lin Xu; Changli Wang; Mingwei Chen; Xiaozheng Kang; Wanpu Yan; Honghong Yan; Riqiang Liao; Jinji Yang; Xuchao Zhang; Qing Zhou; Yilong Wu; Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study, Journal of Clinical Oncology, 2019, 37(25): 2235-2245.

(3) Wenzhao Zhong; Qun Wang; Weimin Mao; Songtao Xu; Wu Lin; Yi Shen; Yongyu Liu; Chun Chen; Ying Cheng; Lin Xu; Jun Wang; Ke Fei; Xiaofei Li; Jian Li; Cheng Huang; Zhidong Liu; Shun Xu; Keneng Chen; Shidong Xu; Lunxu Liu; Ping Yu; Buhai Wang; Haitao Ma; Honghong Yan; Xuening Yang; Qing Zhou; Yilong Wu; Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study, The Lancet Oncology, 2018, 19(1): 139-148.

(4) Jiatao Zhang; Hao Qin; Fiona Ka Man Cheung; Jian Su; Dadong Zhang; Shiyi Liu; Lixiao Fang; Jing Qin; Juntao Lin; Benyuan Jiang; Song Dong; Riqiang Liao; Qiang Nie; Xuening Yang; Haiyan Tu; Qing Zhou; Jinji Yang; Xuchao Zhang; Yanan Zhang; Yilong Wu*; Wenzhao Zhong; Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules, Journal of Extracellular Vesicles, 2019, 8(1): 1663666, 1-13.

(5) Chao Zhang; Jianjun Zhang; Fangping Xu; Yinguang Wang; Zhi Xie; Jian Su; Song Dong; Qiang Nie; Yang Shao; Qing Zhou; Jinji Yang; Xuening Yang; Xuchao Zhang; Zhi Li; Yilong Wu; Wenzhao Zhong; Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma, Journal of Thoracic Oncology, 2019, 14(11):1912-1923.